Luciano Mutti Selected Research

Luciano Mutti Research Topics

Disease

68	Neoplasms (Cancer) 03/2024 - 10/2002
66	Malignant Mesothelioma 01/2023 - 02/2002
36	Mesothelioma 04/2024 - 02/2002
9	Lung Neoplasms (Lung Cancer) 01/2023 - 09/2007
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 01/2020
5	Carcinogenesis 12/2020 - 03/2010
4	Rare Diseases (Rare Disease) 02/2020 - 06/2005
3	Melanoma (Melanoma, Malignant) 01/2020 - 01/2015
3	Genetic Predisposition to Disease (Genetic Predisposition) 07/2008 - 10/2002
2	Inflammation (Inflammations) 03/2024 - 11/2017
2	Brain Neoplasms (Brain Tumor) 03/2023 - 01/2022
2	Adenocarcinoma of Lung 01/2022 - 01/2022
2	Disease Progression 12/2020 - 06/2009
2	Breast Neoplasms (Breast Cancer) 12/2020 - 06/2016
2	Neoplasm Metastasis (Metastasis) 11/2015 - 09/2009
2	Pleural Effusion (Pleural Effusions) 03/2010 - 11/2002
1	Cicatrix (Scar) 03/2024
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023
1	Multiple Myeloma 01/2023
1	Triple Negative Breast Neoplasms 12/2020
1	COVID-19 07/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Disease Resistance 11/2017

Drug/Important Bio-Agent (IBA)

23	AsbestosIBA 03/2024 - 10/2002
12	MMEIBA 01/2023 - 11/2002
7	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2020
7	MesothelinIBA 01/2017 - 09/2007
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2012
4	Pemetrexed (MTA)FDA Link 01/2022 - 08/2007
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2007
4	MicroRNAs (MicroRNA)IBA 01/2020 - 03/2010
4	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 01/2007
4	Tumor Viral Antigens (Large T Antigen)IBA 07/2005 - 01/2003
3	Bortezomib (Velcade)FDA Link 01/2023 - 10/2007
3	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2012
3	Long Noncoding RNAIBA 01/2022 - 01/2022
3	Estrogen ReceptorsIBA 12/2020 - 06/2009
3	Gemcitabine FDA Link 01/2019 - 08/2007
3	Peptides (Polypeptides)IBA 01/2017 - 07/2010
3	tremelimumabIBA 01/2017 - 10/2013
3	Phosphotransferases (Kinase)IBA 11/2015 - 05/2005
3	Estrogen Receptor betaIBA 01/2012 - 06/2009
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2002
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
2	Bevacizumab (Avastin)FDA Link 01/2022 - 08/2017
2	Sirtuin 1IBA 12/2021 - 02/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 02/2002
2	Messenger RNA (mRNA)IBA 12/2020 - 02/2010
2	EnzymesIBA 12/2020 - 12/2009
2	HLA-B Antigens (HLA-B)IBA 07/2020 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 10/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2016
2	Epidermal Growth Factor (EGF)IBA 01/2017 - 03/2010
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017 - 01/2008
2	Small Interfering RNA (siRNA)IBA 11/2015 - 11/2012
2	PolyphenolsIBA 12/2013 - 11/2012
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2013 - 11/2012
2	Gefitinib (Iressa)FDA Link 11/2010 - 03/2010
2	ranpirnase (Pannon)IBA 12/2008 - 05/2005
1	Chymotrypsin FDA Link 01/2023
1	alexidineIBA 05/2022
1	CaspasesIBA 05/2022
1	atezolizumabIBA 01/2022
1	durvalumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	avelumabIBA 01/2022
1	abemaciclibIBA 01/2022
1	Circular RNAIBA 01/2022
1	NivolumabIBA 01/2022
1	Serine (L-Serine)FDA Link 12/2021
1	Lysine (L-Lysine)FDA Link 12/2021
1	Cyclin D1IBA 08/2021
1	Circulating Tumor DNAIBA 05/2021
1	Tumor Biomarkers (Tumor Markers)IBA 05/2021
1	ProcalcitoninIBA 01/2021
1	Protein Disulfide-IsomerasesIBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	HLA-C Antigens (HLA-C)IBA 07/2020
1	51 CIBA 07/2020
1	HLA-A Antigens (HLA-A)IBA 07/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020
1	5'-methylthioadenosineIBA 01/2020
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2020
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2020
1	1-methyl-1-piperidinomethane sulfonateIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA 01/2019
1	LCRF-0004IBA 01/2019
1	SirtuinsIBA 01/2019
1	Hormones (Hormone)IBA 11/2017

Therapy/Procedure

30	Therapeutics 05/2022 - 06/2005
12	Immunotherapy 04/2024 - 10/2011
12	Drug Therapy (Chemotherapy) 01/2023 - 03/2008
7	Radiotherapy 03/2023 - 01/2017
1	Palliative Care (Palliative Therapy) 01/2023
1	Intravenous Administration 01/2023
1	Salvage Therapy 02/2020